Distinguished contributions to understanding p53 tumor suppression in stem cells and breakthrough advances in treating breast cancer have earned two scientists at MD Anderson Cancer Center membership in a notable association of scholars.
Michelle C. Barton, Ph.D., dean, of The University of Texas Graduate School of Biomedical Sciences at Houston (GSBS) and professor of Epigenetics and Molecular Carcinogenesis, and Gabriel Hortobagyi, M.D., professor and of Breast Medical Oncology, have been named Fellows of the American Association for the Advancement of Science (AAAS).
AAAS Fellows are elected by members of the 141-year-old organization. With the induction of Barton and Hortobagyi, MD Anderson’s faculty includes 33 AAAS Fellows.
“Election to AAAS is a great honor that highlights the impressive accomplishments and research excellence of MD Anderson’s two newest Fellows,” said Ronald DePinho, M.D., president of MD Anderson. “We take great pride in our faculty’s distinguished efforts and robust involvement with AAAS. As an institution, we remain committed to the pursuit of exceptional programs that integrate patient care, research, education and prevention.”
To learn more about the research advances made by Barton and Hortobagyi, visit the Newsroom on MD Anderson's website.